Sarah Whelan, PhD
Science Writer
Sarah joined Technology Networks in May 2022 after completing a master’s degree in biochemistry from the University of Kent and a PhD in cancer biology from the University of Leicester, where her research focused on the development of colon cancers. In her role as a science writer and editor, Sarah covers scientific news and a range of other scientific content for the site.
Latest Content
Industry Insight
Non-Hallucinogenic Drug Inspired by Psychedelics Enters First-in-Human Study
To learn more about the progress and development of non-hallucinogenic psychedelic therapies for conditions such as depression, Technology Networks spoke with the head of research and development at Delix Therapeutics, Dr. Eliseo Salinas.
News
Weight Loss Drug Could Benefit Over 90 Million US Adults
A new study suggests that over 90 million US adults that are overweight or obese may benefit from the weight loss drug Wegovy™ (semaglutide), which could prevent 1.5 million cardiovascular events over a 10-year period.
News
Cancer Death Risk From Low-Dose Radiation Is Underestimated, Study Suggests
A new study suggests that prolonged exposure to low-dose radiation – such as for workers in the nuclear industry – is associated with an increased risk of death from cancer.
News
Gene Linked to ALS Disrupts Neuron Structure and Function
A study has described how a gene mutation linked to amyotrophic lateral sclerosis (ALS) disrupts the stability of neurons and “chokes off” their nuclei, impairing their function, and suggests that an anti-cancer drug could improve stability in lab models.
News
Blood Cancer Therapy Granted Accelerated FDA Approval
The FDA has given the green light to Elrexfio™ (elranatamab-bcmm), granting it accelerated approval to treat adults with multiple myeloma – a type of blood cancer – who have received at least four previous rounds of certain therapies.
News
Hearing Loss Restored in Mice Using Gene “Switch”
Researchers reversed hearing loss in mice by restoring the function of a defective gene. The proof-of-concept study suggests that some types of hearing loss caused by reduced gene activity could be reversible.
News
Bacteria Detect DNA Shed by Colon Cancer Tumors in Mice
Engineered bacteria can detect tumor DNA shed by colon cancers into the gastrointestinal (GI) tract in mice, creating the potential for their use as biosensors to detect and respond to disease.
News
First Pill for Postpartum Depression Approved by FDA
The first oral pill specifically for the treatment of postpartum depression (PPD) – Zurzuvae™ (zuranolone) – has been approved by the US Food and Drug Administration.
News
Disrupted Sleeping Patterns Are Associated With Harmful Gut Bacteria
A study has found that changes to our sleeping patterns – such as getting up early on weekdays and lying in on the weekend – are associated with the presence of harmful bacteria in the gut, as well as diet quality and inflammation.
News
Scientists Infected People With Hookworms To Improve Their Metabolic Health
A world-first human trial has revealed that inoculation with live hookworms resulted in modest improvements in insulin resistance in a small study of 40 participants at risk for type 2 diabetes.
Advertisement
